Natural Health Trends Reports Fourth Quarter and Full Year 2025 Financial Results
Rhea-AI Summary
Natural Health Trends (NASDAQ: NHTC) reported preliminary fourth-quarter and full-year 2025 results. Q4 revenue was $9.7 million, down 10% year-over-year but up 3% sequentially. The company recorded a Q4 net loss of $588,000 ($0.05/share) and full-year net loss of $882,000 ($0.08/share).
Management said restructuring initiatives to realize $1.5 million annualized savings are substantially complete. Cash, equivalents and marketable securities were $28.9 million at year-end. The board declared a $0.10 quarterly cash dividend payable Feb 27, 2026.
Positive
- Restructuring to realize $1.5 million annualized savings substantially complete
- Declared $0.10 quarterly cash dividend payable Feb 27, 2026
- Year-end cash and equivalents of $28.9 million
Negative
- Q4 revenue declined 10% YoY
- Active members fell 13.8% year-over-year to 26,650
- Full-year net loss of $882,000 versus 2024 net income
- Operating loss widened to $1.8M for 2025
- Net cash used in operations $6.0M in 2025
Key Figures
Market Reality Check
Peers on Argus
Several e-commerce/online retail peers show mixed moves, but a separate momentum scan flags 3 sector names down around -6.3%, while NHTC is down 1.06% over 24 hours. No same-day peer news headlines are recorded.
Previous Earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Nov 05 | Q3 2025 earnings | Negative | -23.3% | Revenue decline, operating loss, restructuring plan and signaled dividend reduction. |
| Jul 30 | Q2 2025 earnings | Negative | -0.3% | 6% revenue drop, operating loss, cash burn despite maintained $0.20 dividend. |
| Apr 30 | Q1 2025 earnings | Neutral | +0.6% | Small revenue decline with modest net income and stable dividend, mixed signals. |
| Feb 05 | Q4/FY 2024 earnings | Positive | +3.2% | Stable Q4 revenue, full-year profit, strong cash and maintained $0.20 dividend. |
| Oct 30 | Q3 2024 earnings | Positive | +0.3% | Slight revenue growth, positive net income and solid cash with ongoing dividend. |
Earnings releases have typically produced modest single-digit moves, with a notably sharp selloff on the Q3 2025 report. Price reactions generally tracked the underlying tone: weaker revenue and rising losses tended to see negative moves.
Over the past year, NHTC’s earnings reports show a gradual erosion in revenue and profitability. Q3 2025 results on Nov 05 triggered a -23.29% move after highlighting an operating loss and restructuring. Earlier 2025 quarters (Q1–Q2) reported mild revenue declines, shrinking cash and falling Active Members, offset by dividends. The Q4 and full-year 2024 release on Feb 05 showed modest profitability and stronger cash. Today’s Q4 2025 results extend the trend of lower sales, operating losses and reduced cash balances.
Historical Comparison
Past earnings headlines led to average moves of -3.89%, usually reflecting modest revenue erosion, margin pressure, and changing dividend policy similar to this update.
Across 2024–2025 earnings, NHTC shifted from modest profitability with strong cash and a $0.20 dividend toward declining revenue, operating losses, cash drawdown and a lower dividend, alongside restructuring to reduce costs.
Market Pulse Summary
This announcement details Q4 2025 and full-year 2025 results showing lower year-over-year revenue, operating losses and reduced cash balances, partly offset by restructuring aimed at $1.5 million in annualized savings and a continued $0.10 dividend. Compared with prior earnings, it extends trends of declining Active Members and cash usage. Investors may watch future quarters for evidence that cost actions stabilize revenue, restore profitability and improve operating cash flow.
Key Terms
marketable securities financial
Tax Cuts and Jobs Act regulatory
Form 10-K regulatory
AI-generated analysis. Not financial advice.
– Net sales decreased
– Restructuring initiatives to achieve
– Declared a quarterly cash dividend of
LOS ANGELES, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness and “quality of life” products under the NHT Global brand, today announced its financial results for the fourth quarter and full year ended December 31, 2025.
Fourth Quarter 2025 Financial Highlights
| • | Revenue of | |
| • | Operating loss was | |
| • | Net loss was | |
| • | The number of Active Members1 were 26,650 at December 31, 2025 compared to 28,030 at September 30, 2025 and 30,870 at December 31, 2024. | |
| 1 | Natural Health Trends defines Active Members as those that have placed at least one product order with the Company during the preceding twelve-month period. | |
Full Year 2025 Financial Highlights
| • | Revenue of | |
| • | Operating loss was | |
| • | Net loss was | |
Management Commentary
“In the fourth quarter we managed to achieve a
Mr. Sharng continued, “Looking ahead, 2026 marks our 25th Anniversary, a significant milestone for the Company. We have prepared an exciting program, including a big celebration in Hong Kong where we anticipate 1,500 attendees from around the world, signature products and incentives to leverage these moments effectively, and we are focused on making this anniversary a catalyst for renewed momentum.”
Balance Sheet and Cash Flow
| • | Net cash used in operating activities was | |
| • | Total cash, cash equivalents and marketable securities were | |
| • | On February 2, 2026, the Company’s Board of Directors declared a quarterly cash dividend of | |
The Company expects to issue its 2025 audited financial results in late February with its Annual Report on Form 10-K to be filed with the United States Securities and Exchange Commission. These financial results are preliminary and the accompanying financial statements have not been audited or have not yet been reviewed by the Company’s independent accountants. Significant updates and revisions may be required before the release of the Company’s 2025 audited financial results.
Fourth Quarter and Full Year 2025 Financial Results Conference Call
Management will host a conference call to discuss the fourth quarter and full year 2025 financial results today, Wednesday, February 4, 2026 at 11:30 a.m. Eastern Time. The conference call details are as follows:
| Date: | Wednesday, February 4, 2026 |
| Time: | 11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time |
| Dial-in: | 1-800-330-6730 |
| Participant ID: | 992974 |
For those unable to participate during the live broadcast, a replay of the call will be available on the Company's Investor Relations website at https://ir.naturalhealthtrendscorp.com.
About Natural Health Trends Corp.
Natural Health Trends Corp. (NASDAQ: NHTC) is an international direct-selling and e-commerce company operating through its subsidiaries throughout Asia, the Americas, and Europe. The Company markets premium quality personal care products under the NHT Global brand. Additional information can be found on the Company’s website at www.naturalhealthtrendscorp.com.
Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 -- Forward-looking statements in this press release do not constitute guarantees of future performance. Forward-looking statements in this press release include statements relating to the anticipated effect of restructuring activities, including expected operational efficiencies and cost savings resulting therefrom, statements regarding technology investments, future growth and profitability, and statements relating to future dividends, the declaration and payment of which will be at the sole discretion of the Company’s board of directors. Such forward-looking statements are subject to risks and uncertainties that could cause the Company’s actual results to differ materially from those anticipated. Such risks and uncertainties include the risks and uncertainties detailed under the caption “Risk Factors” in Natural Health Trends Corp.’s Annual Report on Form 10-K filed on February 21, 2025 with the Securities and Exchange Commission (SEC), as well as in subsequent reports filed this year with the SEC. The Company assumes no obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.
| NATURAL HEALTH TRENDS CORP. CONSOLIDATED BALANCE SHEETS (In thousands, except share data) | ||||||||
| December 31, | ||||||||
| 2025 | 2024 | |||||||
| (Unaudited) | ||||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 6,813 | $ | 13,533 | ||||
| Marketable securities | 22,060 | 30,407 | ||||||
| Inventories | 2,047 | 3,272 | ||||||
| Other current assets | 3,274 | 3,771 | ||||||
| Total current assets | 34,194 | 50,983 | ||||||
| Property and equipment, net | 153 | 190 | ||||||
| Operating lease right-of-use assets | 1,869 | 2,498 | ||||||
| Restricted cash | 7 | 34 | ||||||
| Deferred tax asset | 289 | 382 | ||||||
| Other assets | 1,916 | 1,272 | ||||||
| Total assets | $ | 38,428 | $ | 55,359 | ||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 555 | $ | 895 | ||||
| Income taxes payable | 5 | 4,908 | ||||||
| Accrued commissions | 1,958 | 2,021 | ||||||
| Other accrued expenses | 1,438 | 1,425 | ||||||
| Deferred revenue | 5,574 | 6,428 | ||||||
| Amounts held in eWallets | 2,838 | 3,286 | ||||||
| Operating lease liabilities | 869 | 1,127 | ||||||
| Other current liabilities | 451 | 709 | ||||||
| Total current liabilities | 13,688 | 20,799 | ||||||
| Deferred tax liability | 180 | 174 | ||||||
| Operating lease liabilities | 1,131 | 1,514 | ||||||
| Total liabilities | 14,999 | 22,487 | ||||||
| Stockholders’ equity: | ||||||||
| Preferred stock | — | — | ||||||
| Common stock | 13 | 13 | ||||||
| Additional paid-in capital | 85,033 | 84,901 | ||||||
| Accumulated deficit | (36,436 | ) | (26,344 | ) | ||||
| Accumulated other comprehensive loss | (784 | ) | (1,301 | ) | ||||
| Treasury stock, at cost | (24,397 | ) | (24,397 | ) | ||||
| Total stockholders’ equity | 23,429 | 32,872 | ||||||
| Total liabilities and stockholders’ equity | $ | 38,428 | $ | 55,359 | ||||
| NATURAL HEALTH TRENDS CORP. CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share data) | ||||||||||||||||
| Three Months Ended December 31, | Year Ended December 31, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| (Unaudited) | (Unaudited) | |||||||||||||||
| Net sales | $ | 9,749 | $ | 10,846 | $ | 39,776 | $ | 42,963 | ||||||||
| Cost of sales | 2,643 | 2,802 | 10,523 | 11,178 | ||||||||||||
| Gross profit | 7,106 | 8,044 | 29,253 | 31,785 | ||||||||||||
| Operating expenses: | ||||||||||||||||
| Commissions expense | 3,926 | 4,549 | 16,302 | 17,571 | ||||||||||||
| Selling, general and administrative expenses | 3,815 | 3,916 | 14,759 | 15,513 | ||||||||||||
| Total operating expenses | 7,741 | 8,465 | 31,061 | 33,084 | ||||||||||||
| Loss from operations | (635 | ) | (421 | ) | (1,808 | ) | (1,299 | ) | ||||||||
| Other income, net | 222 | 396 | 1,241 | 1,919 | ||||||||||||
| Income (loss) before income taxes | (413 | ) | (25 | ) | (567 | ) | 620 | |||||||||
| Income tax provision (benefit) | 175 | (201 | ) | 315 | 48 | |||||||||||
| Net income (loss) | $ | (588 | ) | $ | 176 | $ | (882 | ) | $ | 572 | ||||||
| Net income (loss) per common share: | ||||||||||||||||
| Basic | $ | (0.05 | ) | $ | 0.02 | $ | (0.08 | ) | $ | 0.05 | ||||||
| Diluted | $ | (0.05 | ) | $ | 0.02 | $ | (0.08 | ) | $ | 0.05 | ||||||
| Weighted-average number of common shares outstanding: | ||||||||||||||||
| Basic | 11,507 | 11,478 | 11,496 | 11,467 | ||||||||||||
| Diluted | 11,507 | 11,486 | 11,496 | 11,490 | ||||||||||||
| NATURAL HEALTH TRENDS CORP. CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) | ||||||||
| Year Ended December 31, | ||||||||
| 2025 | 2024 | |||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | (Unaudited) | |||||||
| Net income (loss) | $ | (882 | ) | $ | 572 | |||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||||||||
| Depreciation and amortization | 109 | 131 | ||||||
| Net accretion of marketable securities | (375 | ) | (441 | ) | ||||
| Share-based compensation | 132 | 145 | ||||||
| Noncash lease expense | 1,140 | 1,087 | ||||||
| Deferred income taxes | 102 | 17 | ||||||
| Changes in assets and liabilities: | ||||||||
| Inventories | 1,274 | 1,000 | ||||||
| Other current assets | 1,224 | (113 | ) | |||||
| Other assets | (640 | ) | (421 | ) | ||||
| Accounts payable | (341 | ) | (94 | ) | ||||
| Income taxes payable | (4,902 | ) | (3,862 | ) | ||||
| Accrued commissions | (111 | ) | (19 | ) | ||||
| Other accrued expenses | (7 | ) | 271 | |||||
| Deferred revenue | (854 | ) | 245 | |||||
| Amounts held in eWallets | (445 | ) | (672 | ) | ||||
| Operating lease liabilities | (1,142 | ) | (1,151 | ) | ||||
| Other current liabilities | (279 | ) | (62 | ) | ||||
| Net cash used in operating activities | (5,997 | ) | (3,367 | ) | ||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||
| Purchases of property and equipment | (68 | ) | (57 | ) | ||||
| Purchases of marketable securities | (50,742 | ) | (70,431 | ) | ||||
| Proceeds from maturities of marketable securities | 58,958 | 40,413 | ||||||
| Net cash provided by (used in) investing activities | 8,148 | (30,075 | ) | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||
| Dividends paid | (9,210 | ) | (9,213 | ) | ||||
| Net cash used in financing activities | (9,210 | ) | (9,213 | ) | ||||
| Effect of exchange rates on cash, cash equivalents and restricted cash | 312 | 5 | ||||||
| Net decrease in cash, cash equivalents and restricted cash | (6,747 | ) | (42,650 | ) | ||||
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period | 13,567 | 56,217 | ||||||
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period | $ | 6,820 | $ | 13,567 | ||||
| SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES: | ||||||||
| Right-of-use assets obtained in exchange for operating lease liabilities | $ | 487 | $ | 124 | ||||
CONTACT:
Scott Davidson
Senior Vice President and Chief Financial Officer
Natural Health Trends Corp.
Tel (U.S.): 310-541-0888
investor.relations@nhtglobal.com